Why Virus Stocks Drive Market Volatility
The erratic market response to lukewarm medical research for COVID-19 treatment and vaccine candidates is unlikely to slow as investors pin their hopes for a recovery in the high-risk biotech sector. "In the coming months, the stock market,…